| 1 |
SMMT
|
Summit Therapeutics Inc. |
1,233.43 Bn |
-1,338.33 |
0.00 |
-463.89% |
0.0% |
0.01 Bn |
-105.10 |
| 2 |
ONC
|
BeOne Medicines Ltd. |
458.30 Bn |
6,685.60 |
92.16 |
3.08% |
0.0% |
1.90 Bn |
-8.03 |
| 3 |
VRTX
|
Vertex Pharmaceuticals Inc / Ma |
113.54 Bn |
30.89 |
9.68 |
21.88% |
0.0% |
1.83 Bn |
348.55 |
| 4 |
REGN
|
Regeneron Pharmaceuticals, Inc. |
66.44 Bn |
-363.26 |
145.55 |
14.51% |
0.12% |
2.71 Bn |
123.21 |
| 5 |
ALNY
|
Alnylam Pharmaceuticals, Inc. |
49.96 Bn |
1,146.87 |
15.56 |
3.95% |
0.0% |
3.21 Bn |
0.80 |
| 6 |
ARGX
|
Argenx Se |
48.74 Bn |
32.36 |
25,415.62 |
- |
0.0% |
- |
- |
| 7 |
BNTC
|
Benitec Biopharma Inc. |
40.53 Bn |
-969.17 |
0.00 |
-41.64% |
0.0% |
0.00 Bn |
-14.59 |
| 8 |
INSM
|
INSMED Inc |
31.37 Bn |
-26.50 |
70.18 |
-56.31% |
0.0% |
0.74 Bn |
-12.91 |
| 9 |
BNTX
|
BioNTech SE |
25.46 Bn |
-37.86 |
6.86 |
-2.32% |
0.0% |
1.10 Bn |
-5.64 |
| 10 |
RVMD
|
Revolution Medicines, Inc. |
21.56 Bn |
-22.44 |
0.00 |
-47.32% |
0.0% |
0.41 Bn |
-77.02 |
| 11 |
INCY
|
Incyte Corp |
20.19 Bn |
16.99 |
4.20 |
31.86% |
0.0% |
0.04 Bn |
702.21 |
| 12 |
GMAB
|
Genmab A/S |
19.68 Bn |
13.26 |
5.49 |
31.04% |
0.0% |
0.14 Bn |
6.89 |
| 13 |
RPRX
|
Royalty Pharma plc |
17.45 Bn |
15.38 |
7.41 |
5.55% |
2.64% |
8.95 Bn |
3.74 |
| 14 |
MRNA
|
Moderna, Inc. |
16.60 Bn |
-5.33 |
7.44 |
-30.16% |
0.0% |
0.69 Bn |
0.00 |
| 15 |
ROIV
|
Roivant Sciences Ltd. |
15.35 Bn |
-41.04 |
754.88 |
-6.87% |
0.0% |
0.10 Bn |
0.00 |
| 16 |
BBIO
|
BridgeBio Pharma, Inc. |
14.65 Bn |
-18.38 |
41.41 |
-86.24% |
0.0% |
1.86 Bn |
-5.56 |
| 17 |
ASND
|
Ascendis Pharma A/S |
13.01 Bn |
-47.47 |
17.10 |
-11.41% |
0.0% |
1.23 Bn |
-0.09 |
| 18 |
IONS
|
Ionis Pharmaceuticals Inc |
12.34 Bn |
-48.15 |
12.76 |
-7.89% |
0.0% |
1.49 Bn |
-1.85 |
| 19 |
EXEL
|
Exelixis, Inc. |
12.06 Bn |
17.80 |
5.27 |
35.65% |
0.0% |
0.18 Bn |
0.00 |
| 20 |
MDGL
|
Madrigal Pharmaceuticals, Inc. |
11.33 Bn |
-39.17 |
15.29 |
-27.97% |
0.0% |
0.35 Bn |
-15.51 |
| 21 |
FBRX
|
Forte Biosciences, Inc. |
11.24 Bn |
-217.21 |
0.00 |
-61.53% |
0.0% |
0.00 Bn |
0.00 |
| 22 |
BMRN
|
Biomarin Pharmaceutical Inc |
10.77 Bn |
20.70 |
3.48 |
10.12% |
0.0% |
0.60 Bn |
64.50 |
| 23 |
ARWR
|
Arrowhead Pharmaceuticals, Inc. |
10.65 Bn |
-6,528.00 |
12.84 |
9.17% |
0.0% |
0.73 Bn |
1.22 |
| 24 |
JAZZ
|
Jazz Pharmaceuticals plc |
10.33 Bn |
-28.03 |
2.48 |
-5.54% |
0.0% |
5.41 Bn |
-2.50 |
| 25 |
TECH
|
BIO-TECHNE Corp |
10.28 Bn |
91.53 |
35.45 |
4.82% |
0.5% |
0.39 Bn |
13.49 |
| 26 |
RNA
|
Avidity Biosciences, Inc. |
9.51 Bn |
-17.30 |
455.68 |
-27.99% |
0.0% |
0.05 Bn |
0.00 |
| 27 |
AXSM
|
Axsome Therapeutics, Inc. |
9.07 Bn |
-39.51 |
16.16 |
-72.12% |
0.0% |
0.22 Bn |
-29.34 |
| 28 |
HALO
|
Halozyme Therapeutics, Inc. |
8.58 Bn |
14.40 |
6.90 |
55.18% |
0.0% |
1.51 Bn |
43.01 |
| 29 |
KRYS
|
Krystal Biotech, Inc. |
7.92 Bn |
39.83 |
21.23 |
16.27% |
0.0% |
0.01 Bn |
0.00 |
| 30 |
CYTK
|
Cytokinetics Inc |
7.62 Bn |
-10.14 |
87.43 |
-54.98% |
0.0% |
1.20 Bn |
-17.69 |
| 31 |
NUVL
|
Nuvalent, Inc. |
7.58 Bn |
-19.87 |
0.00 |
-42.75% |
0.0% |
0.00 Bn |
0.00 |
| 32 |
ABVX
|
Abivax S.A. |
7.51 Bn |
-32.69 |
827.27 |
0.0% |
0.0% |
0.09 Bn |
0.00 |
| 33 |
COGT
|
Cogent Biosciences, Inc. |
7.16 Bn |
-24.33 |
0.00 |
-80.45% |
0.0% |
0.06 Bn |
-165.03 |
| 34 |
PRAX
|
Praxis Precision Medicines, Inc. |
6.83 Bn |
-25.01 |
914.86 |
-79.49% |
0.0% |
0.00 Bn |
0.00 |
| 35 |
RYTM
|
Rhythm Pharmaceuticals, Inc. |
6.54 Bn |
-33.09 |
37.53 |
-42.34% |
0.0% |
0.00 Bn |
-7.96 |
| 36 |
PCVX
|
Vaxcyte, Inc. |
6.45 Bn |
-9.82 |
0.00 |
-22.12% |
0.0% |
0.08 Bn |
0.00 |
| 37 |
IBRX
|
ImmunityBio, Inc. |
5.79 Bn |
-16.62 |
70.16 |
-48.87% |
0.0% |
0.86 Bn |
-1.84 |
| 38 |
PTCT
|
Ptc Therapeutics, Inc. |
5.72 Bn |
7.60 |
3.21 |
49.46% |
0.0% |
0.41 Bn |
6.37 |
| 39 |
KYMR
|
Kymera Therapeutics, Inc. |
5.59 Bn |
-18.93 |
127.73 |
-28.61% |
0.0% |
0.08 Bn |
-874.73 |
| 40 |
GPCR
|
Structure Therapeutics Inc. |
5.24 Bn |
-24.87 |
0.00 |
-27.14% |
0.0% |
0.01 Bn |
0.00 |
| 41 |
CRNX
|
Crinetics Pharmaceuticals, Inc. |
5.21 Bn |
-12.32 |
3,396.02 |
-37.71% |
0.0% |
0.05 Bn |
0.00 |
| 42 |
FOLD
|
Amicus Therapeutics, Inc. |
5.03 Bn |
-357.75 |
8.40 |
7.71% |
0.0% |
0.44 Bn |
1.11 |
| 43 |
SRRK
|
Scholar Rock Holding Corp |
5.00 Bn |
-14.16 |
0.00 |
-100.33% |
0.0% |
0.11 Bn |
-138.14 |
| 44 |
PTGX
|
Protagonist Therapeutics, Inc |
4.97 Bn |
108.34 |
23.77 |
7.32% |
0.0% |
0.01 Bn |
0.00 |
| 45 |
BLTE
|
Belite Bio, Inc |
4.90 Bn |
-135.60 |
0.00 |
0.0% |
0.0% |
0.00 Bn |
0.00 |
| 46 |
APGE
|
Apogee Therapeutics, Inc. |
4.75 Bn |
-18.73 |
0.00 |
-42.8% |
0.0% |
0.01 Bn |
0.00 |
| 47 |
CELC
|
Celcuity Inc. |
4.65 Bn |
-28.56 |
0.00 |
-33.96% |
0.0% |
0.32 Bn |
-10.41 |
| 48 |
CRSP
|
CRISPR Therapeutics AG |
4.61 Bn |
-9.45 |
120.30 |
-22.79% |
0.0% |
0.21 Bn |
0.00 |
| 49 |
TGTX
|
Tg Therapeutics, Inc. |
4.51 Bn |
10.08 |
8.48 |
13.25% |
0.0% |
0.25 Bn |
4.22 |
| 50 |
MIRM
|
Mirum Pharmaceuticals, Inc. |
4.48 Bn |
-108.11 |
9.49 |
-4.24% |
0.0% |
0.32 Bn |
-1.84 |
| 51 |
ACAD
|
Acadia Pharmaceuticals Inc |
4.37 Bn |
16.75 |
4.18 |
28.09% |
0.0% |
0.04 Bn |
0.00 |
| 52 |
LEGN
|
Legend Biotech Corp |
4.32 Bn |
-18.02 |
4.75 |
-15.74% |
0.0% |
0.41 Bn |
-9.56 |
| 53 |
IMVT
|
Immunovant, Inc. |
4.29 Bn |
-9.24 |
0.00 |
-88.98% |
0.0% |
0.00 Bn |
0.00 |
| 54 |
VRDN
|
Viridian Therapeutics, Inc.\DE |
4.29 Bn |
-14.19 |
60.54 |
-56.88% |
0.0% |
0.02 Bn |
-118.92 |
| 55 |
ADMA
|
Adma Biologics, Inc. |
4.19 Bn |
19.99 |
8.57 |
32.05% |
0.0% |
0.07 Bn |
19.63 |
| 56 |
LGND
|
Ligand Pharmaceuticals Inc |
4.13 Bn |
85.09 |
16.45 |
4.62% |
0.0% |
0.45 Bn |
17.52 |
| 57 |
CGON
|
CG Oncology, Inc. |
4.06 Bn |
-26.81 |
1,868.03 |
-21.66% |
0.0% |
0.01 Bn |
0.00 |
| 58 |
ACLX
|
Arcellx, Inc. |
4.00 Bn |
-18.36 |
111.47 |
-46.45% |
0.0% |
0.05 Bn |
7.50 |
| 59 |
VKTX
|
Viking Therapeutics, Inc. |
3.75 Bn |
-15.81 |
0.00 |
-33.28% |
0.0% |
0.00 Bn |
0.00 |
| 60 |
CORT
|
Corcept Therapeutics Inc |
3.69 Bn |
35.29 |
4.98 |
9.84% |
0.0% |
0.01 Bn |
-2.79 |
| 61 |
NAMS
|
NewAmsterdam Pharma Co N.V. |
3.50 Bn |
-13.44 |
84.30 |
-30.36% |
0.0% |
0.00 Bn |
0.00 |
| 62 |
TERN
|
Terns Pharmaceuticals, Inc. |
3.39 Bn |
-35.86 |
0.00 |
-32.91% |
0.0% |
0.00 Bn |
0.00 |
| 63 |
LQDA
|
Liquidia Corp |
3.33 Bn |
-27.33 |
48.12 |
-57.91% |
0.0% |
0.20 Bn |
-4.63 |
| 64 |
ARQT
|
Arcutis Biotherapeutics, Inc. |
3.28 Bn |
-73.91 |
10.30 |
-10.57% |
0.0% |
0.11 Bn |
-1.96 |
| 65 |
XENE
|
Xenon Pharmaceuticals Inc. |
3.27 Bn |
-10.67 |
435.64 |
-54.38% |
0.0% |
0.01 Bn |
0.00 |
| 66 |
IDYA
|
IDEAYA Biosciences, Inc. |
3.02 Bn |
-18.82 |
14.08 |
-14.34% |
0.0% |
0.03 Bn |
0.00 |
| 67 |
DNLI
|
Denali Therapeutics Inc. |
2.99 Bn |
-6.00 |
0.00 |
-51.65% |
0.0% |
0.04 Bn |
0.00 |
| 68 |
CNTA
|
Centessa Pharmaceuticals plc |
2.93 Bn |
-12.06 |
195.18 |
-54.43% |
0.0% |
0.12 Bn |
-20.50 |
| 69 |
ERAS
|
Erasca, Inc. |
2.91 Bn |
-22.81 |
0.00 |
-32.6% |
0.0% |
0.05 Bn |
0.00 |
| 70 |
BEAM
|
Beam Therapeutics Inc. |
2.90 Bn |
-6.99 |
52.02 |
-36.74% |
0.0% |
0.15 Bn |
0.00 |
| 71 |
TARS
|
Tarsus Pharmaceuticals, Inc. |
2.86 Bn |
-35.29 |
7.82 |
-17.27% |
0.0% |
0.07 Bn |
-7.98 |
| 72 |
EWTX
|
Edgewise Therapeutics, Inc. |
2.86 Bn |
-18.18 |
0.00 |
-27.99% |
0.0% |
0.00 Bn |
0.00 |
| 73 |
CPRX
|
Catalyst Pharmaceuticals, Inc. |
2.84 Bn |
13.06 |
4.91 |
30.97% |
0.0% |
0.00 Bn |
0.00 |
| 74 |
VERA
|
Vera Therapeutics, Inc. |
2.83 Bn |
-11.24 |
0.00 |
-51.39% |
0.0% |
0.08 Bn |
-32.61 |
| 75 |
ALMS
|
Alumis Inc. |
2.74 Bn |
-11.18 |
123.95 |
-60.04% |
0.0% |
0.04 Bn |
0.00 |
| 76 |
ADPT
|
Adaptive Biotechnologies Corp |
2.68 Bn |
-33.72 |
10.62 |
-16.66% |
0.0% |
0.21 Bn |
-5.76 |
| 77 |
NUVB
|
Nuvation Bio Inc. |
2.67 Bn |
-12.27 |
99.73 |
-39.44% |
0.0% |
0.21 Bn |
-29.64 |
| 78 |
APLS
|
Apellis Pharmaceuticals, Inc. |
2.63 Bn |
58.49 |
2.59 |
11.77% |
0.0% |
0.48 Bn |
2.04 |
| 79 |
BLRX
|
BioLineRx Ltd. |
2.61 Bn |
-876.57 |
204.91 |
9.58% |
0.0% |
0.01 Bn |
0.46 |
| 80 |
WVE
|
Wave Life Sciences Ltd. |
2.59 Bn |
-21.26 |
23.74 |
-78.43% |
0.0% |
0.02 Bn |
0.00 |
| 81 |
IRON
|
Disc Medicine, Inc. |
2.51 Bn |
-13.83 |
0.00 |
-29.38% |
0.0% |
0.03 Bn |
-53.81 |
| 82 |
SYRE
|
Spyre Therapeutics, Inc. |
2.48 Bn |
-16.62 |
0.00 |
-32.51% |
0.0% |
0.00 Bn |
0.00 |
| 83 |
TVTX
|
Travere Therapeutics, Inc. |
2.40 Bn |
-27.13 |
5.51 |
-19.15% |
0.0% |
0.33 Bn |
-6.86 |
| 84 |
OLMA
|
Olema Pharmaceuticals, Inc. |
2.28 Bn |
-15.18 |
0.00 |
-48.25% |
0.0% |
0.00 Bn |
0.00 |
| 85 |
GLPG
|
Galapagos Nv |
2.21 Bn |
-4.32 |
6.54 |
-14.48% |
0.0% |
0.01 Bn |
0.00 |
| 86 |
RARE
|
Ultragenyx Pharmaceutical Inc. |
2.21 Bn |
-3.82 |
3.51 |
-67.82% |
0.0% |
0.86 Bn |
0.00 |
| 87 |
RCUS
|
Arcus Biosciences, Inc. |
2.18 Bn |
-6.38 |
9.07 |
-44.93% |
0.0% |
0.10 Bn |
-41.50 |
| 88 |
PVLA
|
Palvella Therapeutics, Inc. |
2.12 Bn |
-60.50 |
-40,028.17 |
-49.43% |
0.0% |
0.00 Bn |
-3.95 |
| 89 |
SRPT
|
Sarepta Therapeutics, Inc. |
2.10 Bn |
-7.74 |
0.87 |
-9.81% |
0.0% |
1.25 Bn |
0.00 |
| 90 |
AAPG
|
Ascentage Pharma Group International |
2.08 Bn |
-12.88 |
38.22 |
- |
0.0% |
- |
- |
| 91 |
HRMY
|
Harmony Biosciences Holdings, Inc. |
2.06 Bn |
11.12 |
2.50 |
24.96% |
0.0% |
0.17 Bn |
16.05 |
| 92 |
ZLAB
|
Zai Lab Ltd |
2.06 Bn |
-9.95 |
4.66 |
-25.28% |
0.0% |
0.22 Bn |
-42.51 |
| 93 |
MESO
|
Mesoblast Ltd |
2.03 Bn |
-19.89 |
118.15 |
- |
0.0% |
- |
- |
| 94 |
OCUL
|
Ocular Therapeutix, Inc |
2.00 Bn |
-8.01 |
35.84 |
-65.7% |
0.0% |
0.08 Bn |
-19.62 |
| 95 |
AUPH
|
Aurinia Pharmaceuticals Inc. |
1.98 Bn |
25.50 |
7.47 |
18.63% |
0.0% |
0.08 Bn |
18.98 |
| 96 |
DYN
|
Dyne Therapeutics, Inc. |
1.92 Bn |
-4.53 |
0.00 |
-52.13% |
0.0% |
0.12 Bn |
-140.36 |
| 97 |
ARDX
|
Ardelyx, Inc. |
1.91 Bn |
-33.74 |
4.79 |
-9.25% |
0.0% |
0.21 Bn |
-2.03 |
| 98 |
CRVS
|
Corvus Pharmaceuticals, Inc. |
1.90 Bn |
-125.94 |
0.00 |
-20.82% |
0.0% |
0.00 Bn |
0.00 |
| 99 |
MLYS
|
Mineralys Therapeutics, Inc. |
1.85 Bn |
-10.82 |
0.00 |
-29.73% |
0.0% |
0.00 Bn |
0.00 |
| 100 |
SLNO
|
Soleno Therapeutics Inc |
1.85 Bn |
-23.64 |
18.79 |
-13.08% |
0.0% |
0.05 Bn |
-17.00 |
| 101 |
ORKA
|
Oruka Therapeutics, Inc. |
1.83 Bn |
-18.00 |
0.00 |
-20.81% |
0.0% |
0.00 Bn |
0.00 |
| 102 |
VCEL
|
Vericel Corp |
1.83 Bn |
139.58 |
7.06 |
3.4% |
0.0% |
0.10 Bn |
22.27 |
| 103 |
IMNM
|
Immunome Inc. |
1.80 Bn |
-8.09 |
186.29 |
-83.13% |
0.0% |
0.00 Bn |
0.00 |
| 104 |
ZYME
|
Zymeworks Inc. |
1.77 Bn |
-27.85 |
13.13 |
-15.78% |
0.0% |
0.02 Bn |
0.00 |
| 105 |
TYRA
|
Tyra Biosciences, Inc. |
1.76 Bn |
-15.78 |
0.00 |
-39.05% |
0.0% |
0.01 Bn |
0.00 |
| 106 |
SNDX
|
Syndax Pharmaceuticals Inc |
1.75 Bn |
-5.62 |
15.70 |
-64.57% |
0.0% |
0.35 Bn |
-9.74 |
| 107 |
RXRX
|
Recursion Pharmaceuticals, Inc. |
1.71 Bn |
-2.39 |
39.17 |
-57.51% |
0.0% |
0.08 Bn |
0.00 |
| 108 |
IMCR
|
Immunocore Holdings plc |
1.71 Bn |
-58.47 |
4.50 |
-1.28% |
0.0% |
0.44 Bn |
-0.74 |
| 109 |
DNTH
|
Dianthus Therapeutics, Inc. /DE/ |
1.69 Bn |
-13.35 |
548.09 |
-22.82% |
0.0% |
0.00 Bn |
0.00 |
| 110 |
CLDX
|
Celldex Therapeutics, Inc. |
1.67 Bn |
-7.44 |
642.32 |
-37.3% |
0.0% |
0.00 Bn |
0.00 |
| 111 |
UPB
|
Upstream Bio, Inc. |
1.66 Bn |
-13.53 |
593.29 |
-32.23% |
0.0% |
0.00 Bn |
0.00 |
| 112 |
MNKD
|
Mannkind Corp |
1.60 Bn |
54.90 |
5.11 |
16.19% |
0.0% |
0.36 Bn |
1.97 |
| 113 |
GLUE
|
Monte Rosa Therapeutics, Inc. |
1.60 Bn |
76.38 |
8.81 |
5.51% |
0.0% |
0.04 Bn |
0.00 |
| 114 |
STOK
|
Stoke Therapeutics, Inc. |
1.60 Bn |
39.34 |
7.76 |
8.62% |
0.0% |
0.00 Bn |
-2.09 |
| 115 |
AGIO
|
Agios Pharmaceuticals, Inc. |
1.53 Bn |
-3.82 |
34.24 |
-31.29% |
0.0% |
0.04 Bn |
0.00 |
| 116 |
NRIX
|
Nurix Therapeutics, Inc. |
1.50 Bn |
-6.14 |
17.96 |
-55.44% |
0.0% |
0.06 Bn |
0.00 |
| 117 |
MBX
|
MBX Biosciences, Inc. |
1.48 Bn |
-18.39 |
0.00 |
-20.75% |
0.0% |
0.00 Bn |
0.00 |
| 118 |
PHVS
|
Pharvaris N.V. |
1.47 Bn |
-7.63 |
0.00 |
0.0% |
0.0% |
0.00 Bn |
13.20 |
| 119 |
ELVN
|
Enliven Therapeutics, Inc. |
1.43 Bn |
-14.70 |
0.00 |
-20.41% |
0.0% |
0.00 Bn |
0.00 |
| 120 |
FTRE
|
Fortrea Holdings Inc. |
1.43 Bn |
-1.41 |
0.52 |
-50.31% |
0.0% |
1.19 Bn |
-10.21 |
| 121 |
ANAB
|
Anaptysbio, Inc |
1.43 Bn |
-16.86 |
8.42 |
-26.84% |
0.0% |
0.35 Bn |
0.00 |
| 122 |
KOD
|
Kodiak Sciences Inc. |
1.41 Bn |
-6.47 |
0.00 |
-123.74% |
0.0% |
0.16 Bn |
0.00 |
| 123 |
TSHA
|
Taysha Gene Therapies, Inc. |
1.41 Bn |
-14.06 |
222.67 |
-34.68% |
0.0% |
0.07 Bn |
-1,367.89 |
| 124 |
TNGX
|
Tango Therapeutics, Inc. |
1.38 Bn |
-13.75 |
20.78 |
-52.38% |
0.0% |
0.03 Bn |
0.00 |
| 125 |
AMLX
|
Amylyx Pharmaceuticals, Inc. |
1.38 Bn |
-9.25 |
-2,075.54 |
-44.49% |
0.0% |
0.01 Bn |
0.00 |
| 126 |
PGEN
|
Precigen, Inc. |
1.35 Bn |
-3.16 |
213.19 |
-176.76% |
0.0% |
0.10 Bn |
-272.48 |
| 127 |
NTLA
|
Intellia Therapeutics, Inc. |
1.34 Bn |
-3.01 |
23.34 |
-53.61% |
0.0% |
0.10 Bn |
0.00 |
| 128 |
NVAX
|
Novavax Inc |
1.33 Bn |
3.89 |
1.25 |
50.0% |
0.0% |
0.25 Bn |
15.43 |
| 129 |
INVA
|
Innoviva, Inc. |
1.32 Bn |
10.34 |
3.39 |
12.65% |
0.0% |
0.26 Bn |
9.63 |
| 130 |
BHVN
|
Biohaven Ltd. |
1.31 Bn |
-1.68 |
0.00 |
-263.08% |
0.0% |
0.31 Bn |
0.00 |
| 131 |
SVRA
|
Savara Inc |
1.30 Bn |
-11.26 |
0.00 |
-93.14% |
0.0% |
0.03 Bn |
0.00 |
| 132 |
TRVI
|
Trevi Therapeutics, Inc. |
1.29 Bn |
-28.16 |
0.00 |
-24.11% |
0.0% |
0.00 Bn |
-45,888.00 |
| 133 |
RLAY
|
Relay Therapeutics, Inc. |
1.28 Bn |
-4.31 |
153.43 |
-46.69% |
0.0% |
0.03 Bn |
0.00 |
| 134 |
IMTX
|
Immatics N.V. |
1.27 Bn |
-9.32 |
12.75 |
-26.21% |
0.0% |
0.02 Bn |
0.00 |
| 135 |
ABCL
|
AbCellera Biologics Inc. |
1.25 Bn |
-7.30 |
35.47 |
-15.92% |
0.0% |
0.14 Bn |
0.00 |
| 136 |
OCS
|
Oculis Holding AG |
1.24 Bn |
-9.54 |
3,448.71 |
-77.18% |
0.0% |
0.00 Bn |
-123.51 |
| 137 |
SEPN
|
Septerna, Inc. |
1.23 Bn |
-20.87 |
55.67 |
-11.1% |
0.0% |
0.02 Bn |
0.00 |
| 138 |
DAWN
|
Day One Biopharmaceuticals, Inc. |
1.21 Bn |
-7.97 |
9.05 |
-31.77% |
0.0% |
0.00 Bn |
0.00 |
| 139 |
QURE
|
uniQure N.V. |
1.20 Bn |
-5.10 |
76.18 |
-20.62% |
0.0% |
0.53 Bn |
-2.61 |
| 140 |
XERS
|
Xeris Biopharma Holdings, Inc. |
1.19 Bn |
-76.10 |
4.47 |
5.51% |
0.0% |
0.26 Bn |
0.47 |
| 141 |
CAPR
|
Capricor Therapeutics, Inc. |
1.13 Bn |
-13.83 |
101.86 |
-83.42% |
0.0% |
0.01 Bn |
0.00 |
| 142 |
RAPP
|
Rapport Therapeutics, Inc. |
1.12 Bn |
-11.49 |
0.00 |
-18.75% |
0.0% |
0.01 Bn |
0.00 |
| 143 |
SANA
|
Sana Biotechnology, Inc. |
1.11 Bn |
-4.72 |
0.00 |
-58.61% |
0.0% |
0.08 Bn |
0.00 |
| 144 |
EYPT
|
EyePoint, Inc. |
1.07 Bn |
-5.18 |
25.17 |
-92.76% |
0.0% |
0.02 Bn |
-14,682.50 |
| 145 |
MLTX
|
MoonLake Immunotherapeutics |
1.05 Bn |
-4.92 |
0.00 |
-56.85% |
0.0% |
0.08 Bn |
-39.60 |
| 146 |
PHAR
|
Pharming Group N.V. |
1.05 Bn |
2,335.50 |
2.46 |
3.9% |
0.0% |
0.15 Bn |
0.00 |
| 147 |
TBPH
|
Theravance Biopharma, Inc. |
1.03 Bn |
35.21 |
12.86 |
13.16% |
0.0% |
0.04 Bn |
19.73 |
| 148 |
PHAT
|
Phathom Pharmaceuticals, Inc. |
1.03 Bn |
-3.75 |
7.00 |
-138.8% |
0.0% |
0.56 Bn |
-2.91 |
| 149 |
SPRY
|
ARS Pharmaceuticals, Inc. |
1.02 Bn |
-12.74 |
7.14 |
-24.77% |
0.0% |
0.17 Bn |
0.00 |
| 150 |
ADXN
|
Addex Therapeutics Ltd. |
1.00 Bn |
-131.68 |
5,064.10 |
-98.97% |
0.0% |
0.00 Bn |
-1,422.20 |
| 151 |
NBTX
|
Nanobiotix S.A. |
0.99 Bn |
-16.37 |
83.22 |
- |
0.0% |
- |
- |
| 152 |
VTYX
|
Ventyx Biosciences, Inc. |
0.99 Bn |
-9.25 |
0.00 |
-53.25% |
0.0% |
0.01 Bn |
0.00 |
| 153 |
URGN
|
UroGen Pharma Ltd. |
0.98 Bn |
-5.93 |
10.11 |
-102.36% |
0.0% |
0.13 Bn |
-9.45 |
| 154 |
TENX
|
Tenax Therapeutics, Inc. |
0.97 Bn |
-22.49 |
0.00 |
-45.03% |
0.0% |
0.00 Bn |
93,175.23 |
| 155 |
MAZE
|
Maze Therapeutics, Inc. |
0.97 Bn |
-9.54 |
0.00 |
-31.61% |
0.0% |
0.02 Bn |
0.00 |
| 156 |
XNCR
|
Xencor Inc |
0.96 Bn |
-7.31 |
6.37 |
-12.25% |
0.0% |
0.20 Bn |
-2.88 |
| 157 |
INBX
|
Inhibrx Biosciences, Inc. |
0.95 Bn |
-6.10 |
675.21 |
-103.24% |
0.0% |
0.11 Bn |
-16.21 |
| 158 |
CAI
|
Caris Life Sciences, Inc. |
0.93 Bn |
-2.46 |
2.26 |
0.0% |
0.0% |
0.38 Bn |
0.00 |
| 159 |
GHRS
|
GH Research PLC |
0.91 Bn |
-21.28 |
0.00 |
-14.53% |
0.0% |
0.00 Bn |
-76.76 |
| 160 |
ANNX
|
Annexon, Inc. |
0.91 Bn |
-4.37 |
0.00 |
-111.57% |
0.0% |
0.03 Bn |
0.00 |
| 161 |
ORIC
|
Oric Pharmaceuticals, Inc. |
0.91 Bn |
-6.72 |
0.00 |
-32.91% |
0.0% |
0.00 Bn |
0.00 |
| 162 |
BCAX
|
Bicara Therapeutics Inc. |
0.91 Bn |
-7.46 |
0.00 |
-30.02% |
0.0% |
0.00 Bn |
0.00 |
| 163 |
ZBIO
|
Zenas BioPharma, Inc. |
0.88 Bn |
-4.64 |
58.76 |
-70.35% |
0.0% |
0.00 Bn |
0.00 |
| 164 |
ARVN
|
Arvinas, Inc. |
0.87 Bn |
-14.85 |
2.78 |
-8.39% |
0.0% |
0.01 Bn |
0.00 |
| 165 |
GERN
|
Geron Corp |
0.87 Bn |
-10.83 |
4.72 |
-9.57% |
0.0% |
0.25 Bn |
-1.35 |
| 166 |
CMPX
|
Compass Therapeutics, Inc. |
0.84 Bn |
-12.69 |
0.00 |
-30.07% |
0.0% |
0.01 Bn |
0.00 |
| 167 |
VIR
|
Vir Biotechnology, Inc. |
0.83 Bn |
-1.66 |
49.26 |
-52.89% |
0.0% |
0.09 Bn |
0.00 |
| 168 |
IOVA
|
Iovance Biotherapeutics, Inc. |
0.82 Bn |
-2.05 |
3.26 |
-51.12% |
0.0% |
0.05 Bn |
0.00 |
| 169 |
JANX
|
Janux Therapeutics, Inc. |
0.80 Bn |
-7.87 |
80.23 |
-10.22% |
0.0% |
0.02 Bn |
0.00 |
| 170 |
AVBP
|
ArriVent BioPharma, Inc. |
0.79 Bn |
-5.25 |
0.00 |
-49.64% |
0.0% |
0.00 Bn |
0.00 |
| 171 |
MDXG
|
Mimedx Group, Inc. |
0.79 Bn |
19.25 |
2.00 |
20.39% |
0.0% |
0.02 Bn |
-21.91 |
| 172 |
CGEM
|
Cullinan Therapeutics, Inc. |
0.78 Bn |
-3.55 |
0.00 |
-48.01% |
0.0% |
0.00 Bn |
0.00 |
| 173 |
ABUS
|
Arbutus Biopharma Corp |
0.77 Bn |
-18.26 |
52.86 |
-45.57% |
0.0% |
0.00 Bn |
-386.86 |
| 174 |
VALN
|
Valneva SE |
0.77 Bn |
-6.39 |
3.63 |
-24.13% |
0.0% |
0.23 Bn |
-3.05 |
| 175 |
KALV
|
KalVista Pharmaceuticals, Inc. |
0.76 Bn |
-4.15 |
0.00 |
0.0% |
0.0% |
0.15 Bn |
0.00 |
| 176 |
GYRE
|
Gyre Therapeutics, Inc. |
0.75 Bn |
113.29 |
7.02 |
7.05% |
0.0% |
0.00 Bn |
0.00 |
| 177 |
KURA
|
Kura Oncology, Inc. |
0.75 Bn |
-3.47 |
7.23 |
-40.35% |
0.0% |
0.02 Bn |
-135.80 |
| 178 |
KROS
|
Keros Therapeutics, Inc. |
0.74 Bn |
11.52 |
3.01 |
9.9% |
0.0% |
0.02 Bn |
0.00 |
| 179 |
ATAI
|
Atai Beckley N.V. |
0.73 Bn |
-4.75 |
242.84 |
-68.03% |
0.0% |
0.00 Bn |
-71.78 |
| 180 |
OMER
|
Omeros Corp |
0.73 Bn |
-6.04 |
0.00 |
-121.65% |
0.0% |
0.36 Bn |
19.61 |
| 181 |
RGNX
|
REGENXBIO Inc. |
0.73 Bn |
-4.08 |
4.49 |
-33.89% |
0.0% |
0.27 Bn |
-3.22 |
| 182 |
ATXS
|
Astria Therapeutics, Inc. |
0.72 Bn |
-5.81 |
1,021.24 |
-49.94% |
0.0% |
0.00 Bn |
0.00 |
| 183 |
ZVRA
|
Zevra Therapeutics, Inc. |
0.66 Bn |
18.79 |
7.87 |
25.35% |
0.0% |
0.06 Bn |
7.52 |
| 184 |
FULC
|
Fulcrum Therapeutics, Inc. |
0.66 Bn |
-9.30 |
0.00 |
-34.99% |
0.0% |
0.01 Bn |
0.00 |
| 185 |
RIGL
|
Rigel Pharmaceuticals Inc |
0.65 Bn |
5.74 |
2.31 |
82.3% |
0.0% |
0.06 Bn |
16.09 |
| 186 |
REPL
|
Replimune Group, Inc. |
0.63 Bn |
-2.03 |
0.00 |
-89.68% |
0.0% |
0.08 Bn |
-37.89 |
| 187 |
SION
|
Sionna Therapeutics, Inc. |
0.61 Bn |
-8.57 |
0.00 |
-21.45% |
0.0% |
0.01 Bn |
0.00 |
| 188 |
GOSS
|
Gossamer Bio, Inc. |
0.59 Bn |
-3.77 |
13.36 |
-100.61% |
0.0% |
0.20 Bn |
-13.45 |
| 189 |
MGTX
|
MeiraGTx Holdings plc |
0.59 Bn |
-3.47 |
21.34 |
-427.19% |
0.0% |
0.09 Bn |
-12.44 |
| 190 |
DRUG
|
Bright Minds Biosciences Inc. |
0.57 Bn |
-64.35 |
0.00 |
-14.9% |
0.0% |
0.00 Bn |
0.00 |
| 191 |
NKTR
|
Nektar Therapeutics |
0.56 Bn |
-4.63 |
8.94 |
-40.25% |
0.0% |
0.09 Bn |
-3.56 |
| 192 |
LENZ
|
LENZ Therapeutics, Inc. |
0.55 Bn |
-9.41 |
31.65 |
-30.03% |
0.0% |
0.00 Bn |
0.00 |
| 193 |
MRVI
|
Maravai Lifesciences Holdings, Inc. |
0.54 Bn |
-4.46 |
2.81 |
-11.9% |
0.0% |
0.32 Bn |
-2.96 |
| 194 |
PRTC
|
PureTech Health plc |
0.54 Bn |
10.67 |
84.61 |
- |
0.0% |
- |
- |
| 195 |
DSGN
|
Design Therapeutics, Inc. |
0.54 Bn |
-7.94 |
0.00 |
-33.62% |
0.0% |
0.00 Bn |
0.00 |
| 196 |
XOMA
|
XOMA Royalty Corp |
0.54 Bn |
32.23 |
11.36 |
10.39% |
0.0% |
0.13 Bn |
1.82 |
| 197 |
PRME
|
Prime Medicine, Inc. |
0.53 Bn |
-2.70 |
89.19 |
-56.38% |
0.0% |
0.12 Bn |
0.00 |
| 198 |
IVA
|
Inventiva S.A. |
0.53 Bn |
-1.45 |
25.69 |
- |
0.0% |
- |
- |
| 199 |
RAPT
|
RAPT Therapeutics, Inc. |
0.52 Bn |
-4.95 |
0.00 |
-69.33% |
0.0% |
0.00 Bn |
0.00 |
| 200 |
DBVT
|
DBV Technologies S.A. |
0.51 Bn |
-4.06 |
92.24 |
-204.9% |
0.0% |
0.01 Bn |
0.00 |
| 201 |
PRTA
|
Prothena Corp Public Ltd Co |
0.50 Bn |
-1.78 |
42.25 |
-79.27% |
0.0% |
0.01 Bn |
0.00 |
| 202 |
DNA
|
Ginkgo Bioworks Holdings, Inc. |
0.50 Bn |
-1.46 |
2.74 |
-31.66% |
0.0% |
0.42 Bn |
-3,616.71 |
| 203 |
CRMD
|
CorMedix Inc. |
0.49 Bn |
3.03 |
2.30 |
17.5% |
0.0% |
0.15 Bn |
110.79 |
| 204 |
OCGN
|
Ocugen, Inc. |
0.49 Bn |
-7.59 |
90.50 |
-163.12% |
0.0% |
0.03 Bn |
-18.48 |
| 205 |
ZURA
|
Zura Bio Ltd |
0.48 Bn |
-7.71 |
0.00 |
-54.26% |
0.0% |
0.00 Bn |
0.00 |
| 206 |
TECX
|
Tectonic Therapeutic, Inc. |
0.48 Bn |
-7.10 |
0.00 |
-24.75% |
0.0% |
0.00 Bn |
-907.52 |
| 207 |
DRTS
|
Alpha Tau Medical Ltd. |
0.47 Bn |
-13.46 |
0.00 |
- |
0.0% |
- |
- |
| 208 |
ANRO
|
Alto Neuroscience, Inc. |
0.47 Bn |
-7.61 |
0.00 |
-43.51% |
0.0% |
0.03 Bn |
-26.96 |
| 209 |
LXRX
|
Lexicon Pharmaceuticals, Inc. |
0.47 Bn |
-6.89 |
6.67 |
-31.71% |
0.0% |
0.06 Bn |
-5.75 |
| 210 |
NAGE
|
Niagen Bioscience, Inc. |
0.47 Bn |
23.00 |
3.77 |
28.18% |
0.0% |
0.00 Bn |
0.00 |
| 211 |
ENGN
|
enGene Holdings Inc. |
0.47 Bn |
-3.97 |
0.00 |
-60.32% |
0.0% |
0.03 Bn |
-38.18 |
| 212 |
BCYC
|
Bicycle Therapeutics Plc |
0.46 Bn |
-1.84 |
16.30 |
-36.37% |
0.0% |
0.00 Bn |
-1,256.99 |
| 213 |
VNDA
|
Vanda Pharmaceuticals Inc. |
0.45 Bn |
-5.39 |
2.14 |
-22.17% |
0.0% |
0.01 Bn |
0.00 |
| 214 |
AVXL
|
Anavex Life Sciences Corp. |
0.43 Bn |
-9.31 |
0.00 |
-48.89% |
0.0% |
0.00 Bn |
0.00 |
| 215 |
TRDA
|
Entrada Therapeutics, Inc. |
0.43 Bn |
-4.16 |
7.00 |
-26.87% |
0.0% |
0.05 Bn |
0.00 |
| 216 |
FDMT
|
4D Molecular Therapeutics, Inc. |
0.43 Bn |
-2.03 |
3,542.06 |
-54.07% |
0.0% |
0.02 Bn |
0.00 |
| 217 |
ADCT
|
ADC Therapeutics SA |
0.41 Bn |
-2.46 |
5.46 |
-50.64% |
0.0% |
0.12 Bn |
-2.28 |
| 218 |
IMMP
|
IMMUTEP Ltd |
0.41 Bn |
-10.12 |
60.19 |
- |
0.0% |
- |
- |
| 219 |
SLS
|
SELLAS Life Sciences Group, Inc. |
0.40 Bn |
-15.43 |
0.00 |
-56.85% |
0.0% |
0.00 Bn |
0.00 |
| 220 |
ACRS
|
Aclaris Therapeutics, Inc. |
0.40 Bn |
-2.80 |
25.23 |
-94.51% |
0.0% |
0.00 Bn |
0.00 |
| 221 |
NWBO
|
Northwest Biotherapeutics Inc |
0.40 Bn |
-4.33 |
421.88 |
141.78% |
0.0% |
0.08 Bn |
-9.52 |
| 222 |
RCKT
|
Rocket Pharmaceuticals, Inc. |
0.39 Bn |
-1.62 |
0.00 |
-70.95% |
0.0% |
0.03 Bn |
-126.40 |
| 223 |
KYTX
|
Kyverna Therapeutics, Inc. |
0.39 Bn |
-2.42 |
0.00 |
-104.98% |
0.0% |
0.01 Bn |
-2,204.37 |
| 224 |
LCTX
|
Lineage Cell Therapeutics, Inc. |
0.38 Bn |
-5.69 |
35.59 |
-84.3% |
0.0% |
0.00 Bn |
0.00 |
| 225 |
AUTL
|
Autolus Therapeutics plc |
0.38 Bn |
-1.71 |
7.52 |
-40.97% |
0.0% |
0.33 Bn |
13.95 |
| 226 |
VSTM
|
Verastem, Inc. |
0.38 Bn |
-1.56 |
28.20 |
-204.07% |
0.0% |
0.09 Bn |
-127.90 |
| 227 |
CLLS
|
Cellectis S.A. |
0.38 Bn |
-10.64 |
4.56 |
-4.5% |
0.0% |
0.12 Bn |
-0.34 |
| 228 |
SLDB
|
Solid Biosciences Inc. |
0.37 Bn |
-2.24 |
0.00 |
-70.12% |
0.0% |
0.02 Bn |
-309.08 |
| 229 |
CLYM
|
Climb Bio, Inc. |
0.37 Bn |
-7.32 |
0.00 |
-28.62% |
0.0% |
0.00 Bn |
0.00 |
| 230 |
CTMX
|
CytomX Therapeutics, Inc. |
0.37 Bn |
13.10 |
3.23 |
24.11% |
0.0% |
0.01 Bn |
0.00 |
| 231 |
ABSI
|
Absci Corp |
0.37 Bn |
-3.19 |
129.74 |
-52.98% |
0.0% |
0.01 Bn |
-394.68 |
| 232 |
SABS
|
SAB Biotherapeutics, Inc. |
0.36 Bn |
19.45 |
3,177.67 |
11.0% |
0.0% |
0.01 Bn |
76.54 |
| 233 |
NGNE
|
Neurogene Inc. |
0.36 Bn |
-4.26 |
0.00 |
-31.17% |
0.0% |
0.01 Bn |
-14,187.33 |
| 234 |
FHTX
|
Foghorn Therapeutics Inc. |
0.36 Bn |
-4.93 |
14.50 |
-60.16% |
0.0% |
0.02 Bn |
0.00 |
| 235 |
MCRB
|
Seres Therapeutics, Inc. |
0.35 Bn |
65.48 |
1,006.24 |
4.46% |
0.0% |
0.09 Bn |
0.00 |
| 236 |
MNPR
|
Monopar Therapeutics |
0.35 Bn |
-17.76 |
0.00 |
-13.73% |
0.0% |
0.00 Bn |
0.00 |
| 237 |
ALLO
|
Allogene Therapeutics, Inc. |
0.34 Bn |
-1.60 |
0.00 |
-51.66% |
0.0% |
0.00 Bn |
-249.98 |
| 238 |
LYEL
|
Lyell Immunopharma, Inc. |
0.34 Bn |
-1.04 |
9,944.39 |
-86.59% |
0.0% |
0.04 Bn |
0.00 |
| 239 |
DMAC
|
DiaMedica Therapeutics Inc. |
0.33 Bn |
-10.45 |
0.00 |
-61.7% |
0.0% |
0.00 Bn |
0.00 |
| 240 |
ALT
|
Altimmune, Inc. |
0.33 Bn |
-3.95 |
22,115.92 |
-40.73% |
0.0% |
0.01 Bn |
-110.16 |
| 241 |
ACIU
|
AC Immune SA |
0.33 Bn |
-3.69 |
60.64 |
-97.78% |
0.0% |
0.01 Bn |
-398.28 |
| 242 |
PBYI
|
Puma Biotechnology, Inc. |
0.33 Bn |
8.80 |
1.53 |
32.49% |
0.0% |
0.04 Bn |
4.81 |
| 243 |
CTNM
|
Contineum Therapeutics, Inc. |
0.31 Bn |
-5.24 |
0.00 |
-32.19% |
0.0% |
0.01 Bn |
0.00 |
| 244 |
NMRA
|
Neumora Therapeutics, Inc. |
0.30 Bn |
-1.27 |
0.00 |
-154.89% |
0.0% |
0.02 Bn |
-315.15 |
| 245 |
ARTV
|
Artiva Biotherapeutics, Inc. |
0.30 Bn |
-3.76 |
0.00 |
-57.49% |
0.0% |
0.01 Bn |
0.00 |
| 246 |
AVIR
|
Atea Pharmaceuticals, Inc. |
0.29 Bn |
-1.94 |
0.00 |
-45.29% |
0.0% |
0.00 Bn |
0.00 |
| 247 |
IVVD
|
Invivyd, Inc. |
0.29 Bn |
-4.77 |
5.70 |
-63.24% |
0.0% |
0.00 Bn |
0.00 |
| 248 |
GLSI
|
Greenwich LifeSciences, Inc. |
0.28 Bn |
-14.58 |
0.00 |
-891.35% |
0.0% |
0.00 Bn |
0.00 |
| 249 |
LXEO
|
Lexeo Therapeutics, Inc. |
0.28 Bn |
-2.69 |
0.00 |
-82.85% |
0.0% |
0.01 Bn |
-998.68 |
| 250 |
ALDX
|
Aldeyra Therapeutics, Inc. |
0.28 Bn |
-6.51 |
0.00 |
-83.73% |
0.0% |
0.02 Bn |
-21.72 |
| 251 |
PROK
|
Prokidney Corp. |
0.28 Bn |
-3.89 |
371.48 |
-20.87% |
0.0% |
0.00 Bn |
-13,465.40 |
| 252 |
ABEO
|
Abeona Therapeutics Inc. |
0.28 Bn |
3.34 |
687.54 |
41.45% |
0.0% |
0.02 Bn |
21.99 |
| 253 |
AURA
|
Aura Biosciences, Inc. |
0.27 Bn |
-2.56 |
0.00 |
-62.12% |
0.0% |
0.02 Bn |
0.00 |
| 254 |
EPRX
|
Eupraxia Pharmaceuticals Inc. |
0.27 Bn |
-9.23 |
0.00 |
-33.21% |
0.0% |
0.00 Bn |
-214,649.38 |
| 255 |
ENTA
|
Enanta Pharmaceuticals Inc |
0.27 Bn |
-3.25 |
4.08 |
-32.68% |
0.0% |
0.06 Bn |
-9.88 |
| 256 |
RNAC
|
Cartesian Therapeutics, Inc. |
0.26 Bn |
-5.09 |
236.18 |
-13.29% |
0.0% |
0.01 Bn |
0.00 |
| 257 |
NAUT
|
Nautilus Biotechnology, Inc. |
0.26 Bn |
-4.10 |
0.00 |
-32.73% |
0.0% |
0.03 Bn |
0.00 |
| 258 |
CADL
|
Candel Therapeutics, Inc. |
0.25 Bn |
-10.96 |
0.00 |
-26.21% |
0.0% |
0.01 Bn |
-19.82 |
| 259 |
HRTX
|
Heron Therapeutics, Inc. /De/ |
0.24 Bn |
-17.75 |
1.55 |
-6.97% |
0.0% |
0.14 Bn |
-4.47 |
| 260 |
RZLT
|
Rezolute, Inc. |
0.24 Bn |
-3.11 |
0.00 |
-51.99% |
0.0% |
0.00 Bn |
0.00 |
| 261 |
SLN
|
Silence Therapeutics plc |
0.24 Bn |
-3.57 |
9.12 |
-52.83% |
0.0% |
0.00 Bn |
6.34 |
| 262 |
EVMN
|
Evommune, Inc. |
0.24 Bn |
-3.46 |
33.75 |
0.0% |
0.0% |
0.00 Bn |
0.00 |
| 263 |
STTK
|
Shattuck Labs, Inc. |
0.23 Bn |
-4.25 |
233.57 |
-57.79% |
0.0% |
0.00 Bn |
0.00 |
| 264 |
VTVT
|
vTv Therapeutics Inc. |
0.23 Bn |
-9.82 |
13,552.56 |
-26.27% |
0.0% |
0.00 Bn |
-4,693.00 |
| 265 |
LRMR
|
Larimar Therapeutics, Inc. |
0.22 Bn |
-1.65 |
0.00 |
-92.8% |
0.0% |
0.00 Bn |
0.00 |
| 266 |
ASMB
|
Assembly Biosciences, Inc. |
0.22 Bn |
-5.59 |
0.00 |
-20.7% |
0.0% |
0.00 Bn |
0.00 |
| 267 |
ARMP
|
Armata Pharmaceuticals, Inc. |
0.21 Bn |
-4.58 |
173.99 |
63.18% |
0.0% |
0.18 Bn |
-2.12 |
| 268 |
TARA
|
Protara Therapeutics, Inc. |
0.21 Bn |
-4.06 |
0.00 |
-39.27% |
0.0% |
0.00 Bn |
0.00 |
| 269 |
VYGR
|
Voyager Therapeutics, Inc. |
0.21 Bn |
-1.69 |
6.85 |
-49.86% |
0.0% |
0.04 Bn |
0.00 |
| 270 |
ACHV
|
Achieve Life Sciences, Inc. |
0.21 Bn |
-3.98 |
0.00 |
-121.91% |
0.0% |
0.01 Bn |
-67.43 |
| 271 |
ZNTL
|
Zentalis Pharmaceuticals, Inc. |
0.21 Bn |
-1.39 |
-5.10 |
-51.54% |
0.0% |
0.04 Bn |
0.00 |
| 272 |
SLGL
|
Sol-Gel Technologies Ltd. |
0.21 Bn |
-60.59 |
8.63 |
0.0% |
0.0% |
0.00 Bn |
0.00 |
| 273 |
FENC
|
Fennec Pharmaceuticals Inc. |
0.21 Bn |
-29.56 |
5.29 |
-9.73% |
0.0% |
0.02 Bn |
-1.40 |
| 274 |
OABI
|
OmniAb, Inc. |
0.21 Bn |
-3.22 |
9.72 |
-22.59% |
0.0% |
0.02 Bn |
0.00 |
| 275 |
SGMT
|
Sagimet Biosciences Inc. |
0.20 Bn |
-3.53 |
0.00 |
-48.36% |
0.0% |
0.00 Bn |
0.00 |
| 276 |
CGEN
|
Compugen Ltd |
0.20 Bn |
-7.27 |
29.07 |
-35.53% |
0.0% |
0.00 Bn |
0.00 |
| 277 |
PEPG
|
PepGen Inc. |
0.20 Bn |
-2.11 |
0.00 |
-53.08% |
0.0% |
0.02 Bn |
0.00 |
| 278 |
WHWK
|
Whitehawk Therapeutics, Inc. |
0.20 Bn |
-12.50 |
13.57 |
-9.94% |
0.0% |
0.00 Bn |
0.00 |
| 279 |
ARCT
|
Arcturus Therapeutics Holdings Inc. |
0.19 Bn |
-2.89 |
1.97 |
-32.68% |
0.0% |
0.02 Bn |
5.39 |
| 280 |
GALT
|
Galectin Therapeutics Inc |
0.19 Bn |
-5.07 |
0.00 |
24.43% |
0.0% |
0.12 Bn |
-4.24 |
| 281 |
MDWD
|
MediWound Ltd. |
0.19 Bn |
-9.19 |
9.05 |
-24.94% |
0.0% |
0.01 Bn |
-4.87 |
| 282 |
ALEC
|
Alector, Inc. |
0.19 Bn |
-1.73 |
2.69 |
-42.18% |
0.0% |
0.04 Bn |
0.00 |
| 283 |
CHRS
|
Coherus Oncology, Inc. |
0.18 Bn |
1.17 |
2.16 |
115.84% |
0.0% |
0.04 Bn |
13.81 |
| 284 |
CRDF
|
Cardiff Oncology, Inc. |
0.18 Bn |
-3.56 |
358.15 |
-102.75% |
0.0% |
0.00 Bn |
0.00 |
| 285 |
AARD
|
Aardvark Therapeutics, Inc. |
0.18 Bn |
-3.61 |
0.00 |
-39.82% |
0.0% |
0.00 Bn |
0.00 |
| 286 |
PRQR
|
ProQR Therapeutics N.V. |
0.17 Bn |
-3.48 |
9.22 |
-44.87% |
0.0% |
0.02 Bn |
-25.15 |
| 287 |
CNTX
|
Context Therapeutics Inc. |
0.17 Bn |
-6.42 |
0.00 |
-36.12% |
0.0% |
0.00 Bn |
0.00 |
| 288 |
EDIT
|
Editas Medicine, Inc. |
0.17 Bn |
-0.85 |
3.66 |
-143.62% |
0.0% |
0.08 Bn |
167.53 |
| 289 |
FBIO
|
Fortress Biotech, Inc. |
0.17 Bn |
-31.64 |
2.71 |
11.79% |
0.0% |
0.07 Bn |
1.41 |
| 290 |
IMRX
|
Immuneering Corp |
0.17 Bn |
-2.67 |
0.00 |
-26.99% |
0.0% |
0.00 Bn |
0.00 |
| 291 |
OBIO
|
Orchestra BioMed Holdings, Inc. |
0.17 Bn |
-2.22 |
59.16 |
-88.59% |
0.0% |
0.03 Bn |
-135.30 |
| 292 |
NVCT
|
Nuvectis Pharma, Inc. |
0.16 Bn |
-5.92 |
0.00 |
-115.81% |
0.0% |
0.00 Bn |
0.00 |
| 293 |
HUMA
|
Humacyte, Inc. |
0.16 Bn |
-4.43 |
104.36 |
-39.9% |
0.0% |
0.05 Bn |
-2.47 |
| 294 |
QNCX
|
Quince Therapeutics, Inc. |
0.16 Bn |
-2.83 |
0.00 |
-67.86% |
0.0% |
0.02 Bn |
0.00 |
| 295 |
IPSC
|
Century Therapeutics, Inc. |
0.16 Bn |
-6.00 |
1.40 |
-11.09% |
0.0% |
0.04 Bn |
0.00 |
| 296 |
PLX
|
Protalix BioTherapeutics, Inc. |
0.16 Bn |
29.29 |
2.55 |
12.37% |
0.0% |
0.01 Bn |
7.65 |
| 297 |
CCCC
|
C4 Therapeutics, Inc. |
0.16 Bn |
-1.31 |
5.16 |
-51.82% |
0.0% |
0.06 Bn |
0.00 |
| 298 |
NKTX
|
Nkarta, Inc. |
0.15 Bn |
-1.49 |
0.00 |
-25.13% |
0.0% |
0.08 Bn |
0.00 |
| 299 |
IPHA
|
Innate Pharma SA |
0.15 Bn |
-2.80 |
10.19 |
- |
0.0% |
- |
- |
| 300 |
IKT
|
Inhibikase Therapeutics, Inc. |
0.15 Bn |
-3.18 |
0.00 |
-65.37% |
0.0% |
0.00 Bn |
0.00 |